1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 77,50 | 79,00 | 26.07. | |
| 77,50 | 79,00 | 26.07. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 19.07. | Earnings call: NVE Corporation weathers semiconductor downturn | 1 | Investing.com | ||
| 18.07. | NVE Corp (NVEC) Q1 Earnings Fall Y/Y on Lower Product Sales | 1 | Zacks | ||
| 17.07. | NVE declares $1.00 dividend | 2 | Seeking Alpha | ||
| 17.07. | NVE GAAP EPS of $0.85, revenue of $6.78M | 1 | Seeking Alpha | ||
| 17.07. | NVE CORP /NEW/ - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 17.07. | NVE CORP /NEW/ - 8-K, Current Report | 1 | SEC Filings | ||
| 17.07. | NVE Corporation Reports First Quarter Results and Announces Quarterly Dividend | 3 | GlobeNewswire (USA) | ||
| 10.07. | NVE Corporation: NVE Schedules Conference Call on First-Quarter Results | 4 | GlobeNewswire (USA) | ||
| 29.05. | Zacks Initiates Coverage of NVE Corp With Neutral Recommendation | 3 | Zacks | ||
| 13.05. | Dr. Kelly Wei Joins NVE Corporation's Board of Directors | 2 | GlobeNewswire (USA) | ||
| 13.05. | NVE CORP /NEW/ - 8-K, Current Report | 1 | SEC Filings | ||
| 10.05. | Dividendenbekanntmachungen (10.05.2024) | 10.310 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AAK AB SE0011337708 3,7 SEK 0,3163 EUR ADDLIFE AB SE0014401378 0,5 SEK 0,0427 EUR ALEXANDERS INC US0147521092 4,5 USD 4,1738... ► Artikel lesen | |
| 06.05. | NVE Corporation Announces Death of Board Member Richard W. Kramp | 310 | GlobeNewswire (Europe) | EDEN PRAIRIE, Minn., May 06, 2024 (GLOBE NEWSWIRE) -- NVE Corporation (Nasdaq: NVEC) announced with sadness that Richard W. Kramp, a member of the Company's Board of Directors, passed away after... ► Artikel lesen | |
| 02.05. | Earnings call: NVE Corporation reports strong earnings amid revenue dip | 6 | Investing.com | ||
| 02.05. | NVE declares $1.00 dividend | 3 | Seeking Alpha | ||
| 02.05. | NVE GAAP EPS of $0.79, revenue of $7.08M | 3 | Seeking Alpha | ||
| 01.05. | NVE CORP /NEW/ - 10-K, Annual Report | 1 | SEC Filings | ||
| 01.05. | NVE Corporation Reports Fourth Quarter and Fiscal Year Results and Announces Quarterly Dividend | 247 | GlobeNewswire (Europe) | EDEN PRAIRIE, Minn., May 01, 2024 (GLOBE NEWSWIRE) -- NVE Corporation (Nasdaq: NVEC) announced today financial results for the quarter and fiscal year ended March 31, 2024. Total revenue for the fourth... ► Artikel lesen | |
| 24.04. | NVE Corporation: NVE Schedules Conference Call on Fourth-Quarter and Fiscal Year Results | 2 | GlobeNewswire (USA) | ||
| 28.02. | NVE Nurtures Growth and Provides Investors with Value. | 8 | Benzinga.com |
Seite:
1 2 Weiter >>
25 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FORMYCON | 51,90 | +5,06 % | EQS-Adhoc: Formycon AG: Stelara® Biosimilar-Kandidat FYB202 (Ustekinumab) erhält CHMP-Empfehlung der EMA | EQS-Ad-hoc: Formycon AG / Schlagwort(e): Stellungnahme/Zulassungsantrag
Stelara® Biosimilar-Kandidat FYB202 (Ustekinumab) erhält CHMP-Empfehlung der EMA
26.07.2024 / 10:54 CET/CEST
Veröffentlichung... ► Artikel lesen | |
| GAUZY | 10,380 | +8,01 % | Gauzy Ltd. Announces Preliminary Revenue Ranges, Demonstrating Strong Double-Digit Growth for the Second Quarter and First Half 2024 that Exceeded Expectations | TEL AVIV, Israel, July 15, 2024 (GLOBE NEWSWIRE) -- Gauzy Ltd. (Nasdaq: GAUZ) ("Gauzy" or the "Company"), a global leader in vision and light control solutions, today provided preliminary unaudited... ► Artikel lesen | |
| ACACIA RESEARCH | 5,250 | +7,14 % | Acacia Research Reports First Quarter 2024 Financial Results | NEW YORK--(BUSINESS WIRE)--Acacia Research Corporation (Nasdaq: ACTG) ("Acacia" or the "Company") today reported financial results for the three months ended March 31, 2024.
Martin ("MJ") D.... ► Artikel lesen | |
| KOPIN | 1,009 | +1,92 % | Kopin Corporation: Kopin Expands Medical Offerings to Include Spatial Light Modulator That Enable Super-Resolution Microscopes | Ferroelectric LCOS modulators advance open-source research at top Medical, Biomedical and Research Institutions
Kopin Corporation (NASDAQ: KOPN), a leader in cutting-edge high-performance application-specific... ► Artikel lesen | |
| FENDX TECHNOLOGIES | 0,158 | -2,48 % | FendX Technologies Inc.: FendX Completes Successful Pilot Scale-Up Run of REPELWRAP Film with Dunmore | Oakville, Ontario--(Newsfile Corp. - July 24, 2024) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the "Company" or "FendX") a nanotechnology company developing surface protection... ► Artikel lesen | |
| VEECO INSTRUMENTS | 36,000 | -1,10 % | Veeco Instruments Inc.: Veeco Reports Fourth Quarter and Fiscal Year 2023 Financial Results | Fourth Quarter 2023 Highlights: Revenue of $173.9 million, compared with $153.8 million in the same period last yearGAAP net income of $21.6 million, or $0.37 per diluted share, compared with $128.9... ► Artikel lesen | |
| XTPL | 24,350 | -5,07 % | EQS-News: XTPL S.A.: XTPL achieves PLN 5.5 million of commercial sales in H1 2024, two industrial modules delivered to clients | Issuer: XTPL S.A.
/ Key word(s): Preliminary Results/Sales Result
XTPL achieves PLN 5.5 million of commercial sales in H1 2024, two industrial modules delivered to clients
18.07.2024... ► Artikel lesen | |
| ONTO INNOVATION | 177,00 | +1,72 % | (ONTO) - Analyzing Onto Innovation's Short Interest | ||
| ADVANCE ZINCTEK | 0,432 | -1,82 % | ADVANCE ZINCTEK LIMITED: FY24 Loss Before Tax | ||
| NANOFOCUS | 1,250 | 0,00 % | EQS-Adhoc: NanoFocus AG: Ergänzungsverlangen zur Tagesordnung der ordentlichen Hauptversammlung am 28. August 2024 | EQS-Ad-hoc: NanoFocus AG / Schlagwort(e): Hauptversammlung
NanoFocus AG: Ergänzungsverlangen zur Tagesordnung der ordentlichen Hauptversammlung am 28. August 2024
25.07.2024 / 19:27 CET/CEST
Veröffentlichung... ► Artikel lesen | |
| NANOVIRICIDES | 2,080 | +0,97 % | COVID is Here to Stay and NV-387 is a Much Needed Drug Against It, Reminds NanoViricides | SHELTON, CT / ACCESSWIRE / July 24, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage global leader in broad-spectrum antiviral nanomedicines, today reminds the strong... ► Artikel lesen | |
| LEHNER INVESTMENTS | 0,013 | 0,00 % | EQS-DD: LEHNER INVESTMENTS AG: RIMIVY LTD, Verkauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
05.07.2024 / 16:36... ► Artikel lesen | |
| RIBER | 2,470 | 0,00 % | Riber's first-half revenue up 13% year-on-year to €13.7m | ||
| ZENTEK | 0,875 | -6,42 % | Zentek Launches National Sampling Program for ZenGUARD Antimicrobial Surgical Masks | GUELPH, ON / ACCESSWIRE / July 24, 2024 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company announces that it will embark... ► Artikel lesen | |
| GOMSPACE | 0,429 | -1,15 % | GOMSPACE A/S: GomSpace issues a market update highlighting a positive free cashflow in Q2 and a strong improvement on order backlog |
Das Unternehmen NVE CORPORATION kann der Branche Nanotechnologie zugeordnet werden. Die relative Kursveränderung beträgt aktuell -1,91 % bei einem Aktienkurs von 77,00 Euro. Aus der Ausschüttung der letzten 12 Monate von insgesamt 3,68 Euro errechnet sich eine Dividendendrendite von +4,78 %.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NVE CORPORATION finden Sie auf Wallstreet Online.
